Unit of Oncology 1, Department of Oncology, Transplants and New Technologies in Medicine, Azienda Ospedaliera Universitaria Pisana, Via Roma 67, 56126 Pisa, Italy.
Biomed Pharmacother. 2013 Oct;67(8):807-17. doi: 10.1016/j.biopha.2013.08.005. Epub 2013 Aug 26.
Malnutrition, anorexia and cachexia are a common finding in cancer patients. They become more evident with tumor growth and spread. However, the mechanisms by which they are sustained often arise early in the history of cancer. For malnutrition, these mechanisms can involve primary tumor or damage by specific treatment such as anticancer therapies (surgery, chemotherapy, radiotherapy) also in cancers that usually are not directly responsible for nutritional and metabolic status alterations (i.e. bone tumors). For anorexia, meal-related neural or hormonal signals and humoral signals related to body fat or energy storage and the interaction of these signals with the hypothalamus or the hypothalamic inappropriate response play a pathogenetic role. Some cytokines are probably involved in these mechanisms. For cachexia, the production of proinflammatory cytokines by tumour cells is the initial mechanism; the main biochemical mechanisms involved include the ubiquitine proteasome-dependent proteolysis and heat shock proteins. Treatment includes pharmaceutical and nutritional interventions.
营养不良、厌食和恶病质是癌症患者的常见表现。随着肿瘤的生长和扩散,这些表现会变得更加明显。然而,这些表现持续存在的机制往往在癌症的早期就出现了。对于营养不良,这些机制可能涉及原发肿瘤或特定治疗(如手术、化疗、放疗)的损伤,即使在通常不会直接导致营养和代谢状态改变的癌症中也是如此(即骨肿瘤)。对于厌食,与进食相关的神经或激素信号以及与体脂或能量储存相关的体液信号,以及这些信号与下丘脑或下丘脑不适当反应的相互作用,在发病机制中起作用。一些细胞因子可能参与这些机制。对于恶病质,肿瘤细胞产生促炎细胞因子是初始机制;涉及的主要生化机制包括泛素蛋白酶体依赖性蛋白水解和热休克蛋白。治疗包括药物和营养干预。